Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa
An abnormal prothrombin has been detected in a 23 yr-old healthy female and her mother. Both patients appeared to be heterozygous for the abnormality, plasma prothrombin being 50 % of normal using the usual one stage assay, but normal when measured either by using Echis carinatus venom or by immunoa...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 1986-10, Vol.44 (1), p.11-21 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 21 |
---|---|
container_issue | 1 |
container_start_page | 11 |
container_title | Thrombosis research |
container_volume | 44 |
creator | Huisse, Marie-Geneviéve Dreyfus, Marie Guillin, Marie-Claude |
description | An abnormal prothrombin has been detected in a 23 yr-old healthy female and her mother. Both patients appeared to be heterozygous for the abnormality, plasma prothrombin being 50 % of normal using the usual one stage assay, but normal when measured either by using
Echis carinatus venom or by immunoassay. No abnormality in the immunoelectrophoretic pattern was observed. Prothrombin isolation on DEAE Sephadex failed to separate the abnormal population (prothrombin Clamart) from the normal one. The rates of prothrombin activation by factor Xa, in the presence or absence of phospholipids and/ or factor Va, were determined by measuring the production of both clotting and amidolytic activities. The thrombin generation rate from prothrombin isolated from the propositus plasma was 50 % slower than normal whatever the method of measurement and the composition of the activation mixture. Analysis of the final activation products by SDS polyacrylamide gel electrophoresis revealed that equal amounts of prethrombin 2 and thrombin had been formed. Prethrombin 2 Clamart was shown to be resistant to proteolysis upon further incubation with factor Xa, whereas it was readily converted to thrombin by
Echis carinatus venom. Prothrombin Clamart appears to be characterized by an impairment of Arg 320-IIe cleavage by factor Xa. |
doi_str_mv | 10.1016/0049-3848(86)90176-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77191025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0049384886901763</els_id><sourcerecordid>77191025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-5a698b35e4f69a592ee7bd737329253f4c27cbec2fc9ee9f867e3f3b9014de113</originalsourceid><addsrcrecordid>eNp9kE1LAzEURYMotVb_gUIWIroYzcfMJHEhiPhRKOhCN25CJvOikemMJtOq_97UluLKVSDv3Me7B6F9Sk4poeUZIbnKuMzlsSxPFKGizPgGGlIpVMZywTbRcI1so50Y30iCqCoGaMCFFEUhh-j5IXT9a-imlW-xbczUhB6f4_c_v3MTvGl7_On7V1yDA9v7OWATXjBnJBuPIQXBzM0L4OobO2P7LuAvs4u2nGki7K3eEXq6uX68ussm97fjq8tJZrks-6wwpZIVLyB3pTKFYgCiqgUXnClWcJdbJmwFljmrAJSTpQDueJUa5zVQykfoaLk3Hf0xg9jrqY8Wmsa00M2iFqkzJWnVCOVL0IYuxgBOvwefCn9rSvRCqV740gtfWpb6V6nmKXaw2j-rplCvQyuHaX64mptoTeOCaa2Pa0xIVRDGEnaxxCC5mHsIOloPrYXah6RU153__44fFEiR6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77191025</pqid></control><display><type>article</type><title>Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Huisse, Marie-Geneviéve ; Dreyfus, Marie ; Guillin, Marie-Claude</creator><creatorcontrib>Huisse, Marie-Geneviéve ; Dreyfus, Marie ; Guillin, Marie-Claude</creatorcontrib><description>An abnormal prothrombin has been detected in a 23 yr-old healthy female and her mother. Both patients appeared to be heterozygous for the abnormality, plasma prothrombin being 50 % of normal using the usual one stage assay, but normal when measured either by using
Echis carinatus venom or by immunoassay. No abnormality in the immunoelectrophoretic pattern was observed. Prothrombin isolation on DEAE Sephadex failed to separate the abnormal population (prothrombin Clamart) from the normal one. The rates of prothrombin activation by factor Xa, in the presence or absence of phospholipids and/ or factor Va, were determined by measuring the production of both clotting and amidolytic activities. The thrombin generation rate from prothrombin isolated from the propositus plasma was 50 % slower than normal whatever the method of measurement and the composition of the activation mixture. Analysis of the final activation products by SDS polyacrylamide gel electrophoresis revealed that equal amounts of prethrombin 2 and thrombin had been formed. Prethrombin 2 Clamart was shown to be resistant to proteolysis upon further incubation with factor Xa, whereas it was readily converted to thrombin by
Echis carinatus venom. Prothrombin Clamart appears to be characterized by an impairment of Arg 320-IIe cleavage by factor Xa.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/0049-3848(86)90176-3</identifier><identifier>PMID: 3787558</identifier><identifier>CODEN: THBRAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Ltd</publisher><subject>Adult ; Arginine - metabolism ; Biological and medical sciences ; Blood Coagulation Disorders - genetics ; dysprothrombinemia ; Factor X - physiology ; Factor Xa ; Female ; Genetic Variation ; Hematologic and hematopoietic diseases ; Heterozygote ; Humans ; Immunoelectrophoresis, Two-Dimensional ; Medical sciences ; Platelet diseases and coagulopathies ; Prothrombin ; Prothrombin - genetics ; Prothrombin - isolation & purification ; Prothrombin - metabolism ; prothrombin activation ; Prothrombin Time ; Structure-Activity Relationship ; Thrombin - analysis ; Thrombin - metabolism</subject><ispartof>Thrombosis research, 1986-10, Vol.44 (1), p.11-21</ispartof><rights>1986</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-5a698b35e4f69a592ee7bd737329253f4c27cbec2fc9ee9f867e3f3b9014de113</citedby><cites>FETCH-LOGICAL-c386t-5a698b35e4f69a592ee7bd737329253f4c27cbec2fc9ee9f867e3f3b9014de113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0049384886901763$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7895022$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3787558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huisse, Marie-Geneviéve</creatorcontrib><creatorcontrib>Dreyfus, Marie</creatorcontrib><creatorcontrib>Guillin, Marie-Claude</creatorcontrib><title>Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>An abnormal prothrombin has been detected in a 23 yr-old healthy female and her mother. Both patients appeared to be heterozygous for the abnormality, plasma prothrombin being 50 % of normal using the usual one stage assay, but normal when measured either by using
Echis carinatus venom or by immunoassay. No abnormality in the immunoelectrophoretic pattern was observed. Prothrombin isolation on DEAE Sephadex failed to separate the abnormal population (prothrombin Clamart) from the normal one. The rates of prothrombin activation by factor Xa, in the presence or absence of phospholipids and/ or factor Va, were determined by measuring the production of both clotting and amidolytic activities. The thrombin generation rate from prothrombin isolated from the propositus plasma was 50 % slower than normal whatever the method of measurement and the composition of the activation mixture. Analysis of the final activation products by SDS polyacrylamide gel electrophoresis revealed that equal amounts of prethrombin 2 and thrombin had been formed. Prethrombin 2 Clamart was shown to be resistant to proteolysis upon further incubation with factor Xa, whereas it was readily converted to thrombin by
Echis carinatus venom. Prothrombin Clamart appears to be characterized by an impairment of Arg 320-IIe cleavage by factor Xa.</description><subject>Adult</subject><subject>Arginine - metabolism</subject><subject>Biological and medical sciences</subject><subject>Blood Coagulation Disorders - genetics</subject><subject>dysprothrombinemia</subject><subject>Factor X - physiology</subject><subject>Factor Xa</subject><subject>Female</subject><subject>Genetic Variation</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Immunoelectrophoresis, Two-Dimensional</subject><subject>Medical sciences</subject><subject>Platelet diseases and coagulopathies</subject><subject>Prothrombin</subject><subject>Prothrombin - genetics</subject><subject>Prothrombin - isolation & purification</subject><subject>Prothrombin - metabolism</subject><subject>prothrombin activation</subject><subject>Prothrombin Time</subject><subject>Structure-Activity Relationship</subject><subject>Thrombin - analysis</subject><subject>Thrombin - metabolism</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEURYMotVb_gUIWIroYzcfMJHEhiPhRKOhCN25CJvOikemMJtOq_97UluLKVSDv3Me7B6F9Sk4poeUZIbnKuMzlsSxPFKGizPgGGlIpVMZywTbRcI1so50Y30iCqCoGaMCFFEUhh-j5IXT9a-imlW-xbczUhB6f4_c_v3MTvGl7_On7V1yDA9v7OWATXjBnJBuPIQXBzM0L4OobO2P7LuAvs4u2nGki7K3eEXq6uX68ussm97fjq8tJZrks-6wwpZIVLyB3pTKFYgCiqgUXnClWcJdbJmwFljmrAJSTpQDueJUa5zVQykfoaLk3Hf0xg9jrqY8Wmsa00M2iFqkzJWnVCOVL0IYuxgBOvwefCn9rSvRCqV740gtfWpb6V6nmKXaw2j-rplCvQyuHaX64mptoTeOCaa2Pa0xIVRDGEnaxxCC5mHsIOloPrYXah6RU153__44fFEiR6g</recordid><startdate>19861001</startdate><enddate>19861001</enddate><creator>Huisse, Marie-Geneviéve</creator><creator>Dreyfus, Marie</creator><creator>Guillin, Marie-Claude</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19861001</creationdate><title>Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa</title><author>Huisse, Marie-Geneviéve ; Dreyfus, Marie ; Guillin, Marie-Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-5a698b35e4f69a592ee7bd737329253f4c27cbec2fc9ee9f867e3f3b9014de113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adult</topic><topic>Arginine - metabolism</topic><topic>Biological and medical sciences</topic><topic>Blood Coagulation Disorders - genetics</topic><topic>dysprothrombinemia</topic><topic>Factor X - physiology</topic><topic>Factor Xa</topic><topic>Female</topic><topic>Genetic Variation</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Immunoelectrophoresis, Two-Dimensional</topic><topic>Medical sciences</topic><topic>Platelet diseases and coagulopathies</topic><topic>Prothrombin</topic><topic>Prothrombin - genetics</topic><topic>Prothrombin - isolation & purification</topic><topic>Prothrombin - metabolism</topic><topic>prothrombin activation</topic><topic>Prothrombin Time</topic><topic>Structure-Activity Relationship</topic><topic>Thrombin - analysis</topic><topic>Thrombin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huisse, Marie-Geneviéve</creatorcontrib><creatorcontrib>Dreyfus, Marie</creatorcontrib><creatorcontrib>Guillin, Marie-Claude</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huisse, Marie-Geneviéve</au><au>Dreyfus, Marie</au><au>Guillin, Marie-Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>1986-10-01</date><risdate>1986</risdate><volume>44</volume><issue>1</issue><spage>11</spage><epage>21</epage><pages>11-21</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><coden>THBRAA</coden><abstract>An abnormal prothrombin has been detected in a 23 yr-old healthy female and her mother. Both patients appeared to be heterozygous for the abnormality, plasma prothrombin being 50 % of normal using the usual one stage assay, but normal when measured either by using
Echis carinatus venom or by immunoassay. No abnormality in the immunoelectrophoretic pattern was observed. Prothrombin isolation on DEAE Sephadex failed to separate the abnormal population (prothrombin Clamart) from the normal one. The rates of prothrombin activation by factor Xa, in the presence or absence of phospholipids and/ or factor Va, were determined by measuring the production of both clotting and amidolytic activities. The thrombin generation rate from prothrombin isolated from the propositus plasma was 50 % slower than normal whatever the method of measurement and the composition of the activation mixture. Analysis of the final activation products by SDS polyacrylamide gel electrophoresis revealed that equal amounts of prethrombin 2 and thrombin had been formed. Prethrombin 2 Clamart was shown to be resistant to proteolysis upon further incubation with factor Xa, whereas it was readily converted to thrombin by
Echis carinatus venom. Prothrombin Clamart appears to be characterized by an impairment of Arg 320-IIe cleavage by factor Xa.</abstract><cop>New York, NY</cop><pub>Elsevier Ltd</pub><pmid>3787558</pmid><doi>10.1016/0049-3848(86)90176-3</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 1986-10, Vol.44 (1), p.11-21 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_77191025 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Arginine - metabolism Biological and medical sciences Blood Coagulation Disorders - genetics dysprothrombinemia Factor X - physiology Factor Xa Female Genetic Variation Hematologic and hematopoietic diseases Heterozygote Humans Immunoelectrophoresis, Two-Dimensional Medical sciences Platelet diseases and coagulopathies Prothrombin Prothrombin - genetics Prothrombin - isolation & purification Prothrombin - metabolism prothrombin activation Prothrombin Time Structure-Activity Relationship Thrombin - analysis Thrombin - metabolism |
title | Prothrombin clamart : prothrombin variant with defective arg 320-IIe cleavage by factor xa |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A51%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prothrombin%20clamart%20:%20prothrombin%20variant%20with%20defective%20arg%20320-IIe%20cleavage%20by%20factor%20xa&rft.jtitle=Thrombosis%20research&rft.au=Huisse,%20Marie-Genevi%C3%A9ve&rft.date=1986-10-01&rft.volume=44&rft.issue=1&rft.spage=11&rft.epage=21&rft.pages=11-21&rft.issn=0049-3848&rft.eissn=1879-2472&rft.coden=THBRAA&rft_id=info:doi/10.1016/0049-3848(86)90176-3&rft_dat=%3Cproquest_cross%3E77191025%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77191025&rft_id=info:pmid/3787558&rft_els_id=0049384886901763&rfr_iscdi=true |